AXT stock slides on China export permit delays hitting Q4 outlook — key dates ahead
AXT shares fell 11% to $22.99 after the company cut its Q4 revenue forecast to $22.5–$23.5 million, citing delays in Chinese export permits for indium phosphide substrates. Trading volume surged to 18.2 million shares. The revised outlook missed analyst expectations and sent the stock swinging between $21.31 and $26.27 during the session.
